Lamotrigine SyriMed 5mg / ml Oral Suspension

Licence status
Authorised: 02/09/2022
Active substances
Lamotrigine
Dosage Form
Oral suspension
Licence number
PA22697/018/001
Licence holder
Syri Pharma Limited t/a Thame Laboratories

Product documents

Licence information

ATC code
N03AX09 lamotrigine
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
02/09/2022